Fund profile by ISIN IE000B9PQW54
VanEck Genomics and Healthcare Innovators UCITS ETF
Research VanEck Genomics and Healthcare Innovators UCITS ETF by ISIN IE000B9PQW54: TER 0.35%, domicile Ireland, accumulating, and 1-year price performance +38.2%.
ISINIE000B9PQW54
TER0.35%
DomicileIreland
Distribution policyAccumulating
IndexMVIS Global Future Healthcare ESG
Fund size18M
Holdings49
1-year price performance+38.2%
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| CURE.DE | XETRADefault at German brokers | EUR | Ireland | €96K | 4,136 |
| CURE.MI | ETFP | EUR | Ireland | €18K | 800 |
| CURE.SW | SW | CHF | Ireland | €10K | 426 |
| CURG.L | LSE | GBP | Ireland | €8K | 346 |
| CURE.L | LSE | USD | Ireland | €7K | 347 |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 63.59% of the fund, which holds 49 positions in total. As of 2026-09-13.
| Holding | Symbol | Weight |
|---|---|---|
| Moderna Inc | MRNA | 10.35% |
| Regeneron Pharmaceuticals Inc | REGN | 8.00% |
| Veeva Systems Inc Class A | VEEV | 7.89% |
| Vertex Pharmaceuticals Inc | VRTX | 7.53% |
| Natera Inc | NTRA | 7.28% |
| DexCom Inc | DXCM | 6.42% |
| Illumina Inc | ILMN | 4.95% |
| Guardant Health Inc | GH | 4.12% |
| BioNTech SE ADR | BNTX | 3.62% |
| Alnylam Pharmaceuticals Inc | ALNY | 3.43% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.